Strategic Communications and Marketing News Bureau

Imaging agents light up two cancer biomarkers at once to give more complete picture of tumor

CHAMPAIGN, Ill. — Cancer surgeons may soon have a more complete view of tumors during surgery thanks to new imaging agents that can illuminate multiple biomarkers at once, University of Illinois Urbana-Champaign researchers report. The fluorescent nanoparticles, wrapped in the membranes of red blood cells, target tumors better than current clinically approved dyes and can emit two distinct signals in response to just one beam of surgical light, a feature that could help doctors distinguish tumor borders and identify metastatic cancers. 

The imaging agents can be combined with bioinspired cameras, which the researchers previously developed for real-time diagnosis during surgery, said research group leader Viktor Gruev, an Illinois professor of electrical and computer engineering. In a new study in the journal ACS Nano, the researchers demonstrated their new dual-signal nanoparticles in tumor phantoms – 3D models that mimic the features of tumors and their surroundings – and in live mice. 


Two researchers stand holding vials of cancer imaging agents.

Postdoctoral researcher Indrajit Srivastava, left, and electrical and computer engineering professor Viktor Gruev led a team of researchers developing new cancer imaging agents that can light up two cancer biomarkers when lit by one fluorescent wavelength. 

“If you want to find all the cancer, imaging one biomarker is not enough. It could miss some tumors. If you introduce a second or a third biomarker, the likelihood of removing all cancer cells increases, and the likelihood of a better outcome for the patients increases.” said Gruev, who also is a professor in the Carle Illinois College of Medicine. “Multiple-targeted drugs and imaging agents are a recent trend, and our group is driving the trend hard because we have the camera technology that can image multiple signals at once.”

Traditionally, a surgeon removes a tumor and sends it to a pathologist for assessment, a process that can take hours to days, said Illinois postdoctoral researcher Indrajit Srivastava, the first author of the paper. As research has moved toward real-time diagnostics, several challenges have prevented wide application: Many tumor-targeted imaging agents only minimally reach their tumor targets, instead being quickly cleared from the blood stream and accumulating in the liver, Srivastava said. 

“A few people before us have used nanoparticles coated with red blood cells and found they circulate longer – a few days. We saw the same thing in our mice: The membrane-coated nanoparticles circulated longer in blood, with reduced uptake in the liver. Because they were circulating longer, more of the imaging agents accumulated in the tumors, giving us a stronger fluorescent signal,” Srivastava said. 

An artist's rendering of membrane-wrapped nanoparticles binding to markers on a cancer cell and emitting colored light.

One wavelength of laser light during surgery elicits two distinct signals from the membrane-wrapped nanoparticles, one color for each of the two biomarkers that the nanoparticles target. One is common in earlier stages of cancer, and the other indicates later-stage – and possibly metastatic – cancer. 

The two biomarkers targeted by the new imaging agents include one that is prevalent in early cancer and one that is prevalent in late-stage cancer, which is more likely to be metastatic. The researchers found that the probes were effective at distinguishing cancerous tissue from healthy tissue, as well as distinguishing the two signals from each other.

“This is appealing for surgical application, as it could help determine where exactly to make the cut. Having multiple signals gives a more overall picture of the tumor. And it could tell a surgeon, ‘This may be metastatic, you may want to be more aggressive in your removal.’” Srivastava said.

Only needing one wavelength of laser light to elicit multiple signals is another benefit for surgical applications, as it makes the instrumentation much more compact than those requiring multiple lasers for each needed wavelength, Gruev said. 

The researchers plan to develop more tumor-imaging agents that target multiple markers, and to move forward with further preclinical and clinical studies using their dual-signal dyes with surgical goggles they have developed.

“In this battle for ensuring we remove all the cancer cells during surgery, we need investments both in the imaging camera technology and in the tumor targeting agents,” Gruev said. “This work is helping us better realize and guide the holistic approach that we are taking as we are getting closer and closer to clinical trials.”

The U.S. Congressionally Directed Medical Research Programs, the National Institutes of Health and the National Science Foundation supported this work. Gruev also is affiliated with the department of bioengineering, the Beckman Institute for Advanced Science and Technology and the Cancer Center at Illinois

Editor’s notes: To reach Viktor Gruev, email vgruev@illinois.edu. To reach Indrajit Srivastava, email indrajit@illinois.edu.

The paper “Cell-membrane coated nanoparticles for tumor delineation and qualitative estimation of cancer biomarkers at single wavelength excitation in murine and phantom models” is available online

DOI: 10.1021/acsnano.3c00578

 

Read Next

Agriculture Graduate student Andrea Jimena Valdés-Alvarado, left, and food science professor Elvira Gonzalez de Mejia standing in the Edward R. Madigan Laboratory holding samples of the legume pulses they used in the study.

Fermenting legume pulses boosts their antidiabetic, antioxidant properties

CHAMPAIGN, Ill. — Food scientists at the University of Illinois Urbana-Champaign identified the optimal fermentation conditions for pulses ― the dried edible seeds of legumes ― that increased their antioxidant and antidiabetic properties and their soluble protein content. Using the bacteria Lactiplantibacillus plantarum 299v as the microorganism, the team fermented pulses obtained from varying concentrations […]

Expert viewpoints Ukraine’s daring drone attack deep within Russia is significant but not war-redefining, and may hinder U.S. efforts to end the war, says University of Illinois Urbana-Champaign political science professor and international relations expert Nicholas Grossman.

Does Ukraine drone attack inside Russia augur new era of asymmetric warfare?

Champaign, Ill. — University of Illinois Urbana-Champaign political science professor Nicholas Grossman is the author of “Drones and Terrorism: Asymmetric Warfare and the Threat to Global Security” and specializes in international relations. Grossman spoke with News Bureau business and law editor Phil Ciciora about “Operation Spiderweb,” Ukraine’s expertly plotted drone attack inside the Russian mainland. […]

Behind the scenes Photo of a man with his leg lifted and his boot in the foreground, while another man in the foreground reacts.

Staging a fight

CHAMPAIGN, Ill. — A group of theatre students is gathered in a rehearsal room at Krannert Center for the Performing Arts at the University of Illinois Urbana-Champaign. They are each paired with a partner, and I watch as they shove each other in the chest, knee one another in the gut and then punch their […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010